Business News›Mutual Funds›ICICI Prudential Mutual Fund › ICICI Prudential Nifty Pharma Index Fund Direct - Growth
ICICI Prudential Nifty Pharma Index Fund Direct - ...
Unrated
NAV as of May 23, 2025
16.53-0.40%
- Growth - Direct
(Earn upto 0.61% Extra Returns with Direct Plan)
Fund Category:
Equity: Sectoral-Pharma
Expense Ratio:
0.37%(0.72% Category
average)Fund Size:
Rs. 83.25 Cr(0.28% of Investment in Category)
- ADD TO PORTFOLIO
Loading...
ADD TO PORTFOLIO
ICICI Prudential Nifty Pharma Index Fund Direct - Growth
Unrated
NAV as of May 23, 2025
16.53-0.40%
Expense Ratio:
0.37%
Fund Size:
Rs. 83.25 Cr
Fund Category:
Equity: Sectoral-Pharma
ICICI Prudential Nifty Pharma Index Fund Direct - Growth Fund Key Highlights
1. Current NAV: The Current Net Asset Value of the ICICI Prudential Nifty Pharma Index Fund - Direct Plan as of May 23, 2025 is Rs 16.53 for Growth option of its Direct plan.
2. Returns: Its trailing returns over different time periods are: 13.91% (1yr) and 23.55% (since launch). Whereas, Category returns for the same time duration are: 17.4% (1yr), 22.51% (3yr) and 22.48% (5yr).
3. Fund Size: The ICICI Prudential Nifty Pharma Index Fund - Direct Plan currently holds Assets under Management worth of Rs 83.25 crore as on Apr 30, 2025.
4. Expense ratio: The expense ratio of the fund is 0.37% for Direct plan as on May 15, 2025.
5. Exit Load: The given fund doesn't attract any Exit Load.
6. Minimum Investment: Minimum investment required is Rs 1000 and minimum additional investment is Rs 1000. Minimum SIP investment is Rs 1000.
1. Current NAV: The Current Net Asset Value of the ICICI Prudential Nifty Pharma Index Fund - Direct Plan as of May 23, 2025 is Rs 16.53 for Growth option of its Direct plan.
2. Returns: Its trailing returns over different time periods are: 13.91% (1yr) and 23.55% (since launch). Whereas, Category returns for the same time duration are: 17.4% (1yr), 22.51% (3yr) and 22.48% (5yr).
3. Fund Size: The ICICI Prudential Nifty Pharma Index Fund - Direct Plan currently holds Assets under Management worth of Rs 83.25 crore as on Apr 30, 2025.
4. Expense ratio: The expense ratio of the fund is 0.37% for Direct plan as on May 15, 2025.
5. Exit Load: The given fund doesn't attract any Exit Load.
6. Minimum Investment: Minimum investment required is Rs 1000 and minimum additional investment is Rs 1000. Minimum SIP investment is Rs 1000.
ICICI Prudential Nifty Pharma Index Fund Direct - Growth Returns
Trailing Returns
Rolling Returns
Discrete Period
SIP Returns
1M 3M 6M 1Y 3Y 5Y Annualized Returns -1.43 5.08 -2.28 11.57 - - Category Avg -0.46 6.71 -1.34 17.07 22.19 21.71 Rank within Category 18 18 13 14 - - No. of funds within Category 25 25 22 21 13 8 - Loading...
- Loading...
Return Comparison
- This Fund
- BenchmarkNIFTY Pharma Total Return Index
Choose from Benchmarks
- S&P BSE Sensex
- Nifty 50
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...
ICICI Prudential Nifty Pharma Index Fund Direct - Growth Fund Details
Investment Objective - The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
| Fund House | ICICI Prudential Mutual Fund |
| Launch Date | Dec 14, 2022 |
| Benchmark | NIFTY Pharma Total Return Index |
| Return Since Launch | 22.87% |
| Riskometer | Very High |
| Type | Open-ended |
| Risk Grade | - |
| Return Grade | - |
ICICI Prudential Nifty Pharma Index Fund Direct - Growth Investment Details
| Minimum Investment (Rs.) | 1,000.00 |
| Minimum Additional Investment (Rs.) | 1,000.00 |
| Minimum SIP Investment (Rs.) | 1,000.00 |
| Minimum Withdrawal (Rs.) | - |
| Exit Load | 0% |
Portfolio Allocation
Asset Allocation
Loading...
Asset Allocation History
Loading...
EquityDebtCash
Sector Allocation
Loading...
Market Cap Allocation
Loading...
Concentration & Valuation Analysis
| APR 2025 | MAR 2025 | FEB 2025 | JAN 2025 | DEC 2024 | NOV 2024 | |
|---|---|---|---|---|---|---|
| Number of Holdings | 20 | 20 | 20 | 20 | 20 | 20 |
| Top 5 Company Holdings | 62.62% | 60.88% | 62.08% | 61.62% | 61.49% | 61.55% |
| Top 10 Company Holdings | 81.7% | 79.86% | 80.37% | 80.16% | 80.06% | 80.07% |
| Company with Highest Exposure | Sun Pharmaceutical Industries (25.51%) | Sun Pharmaceutical Industries (24.74%) | Sun Pharmaceutical Industries (24.66%) | Sun Pharmaceutical Industries (24.96%) | Sun Pharmaceutical Industries (24.72%) | Sun Pharmaceutical Industries (24.77%) |
| Number of Sectors | 1 | 1 | 1 | 1 | 1 | 1 |
| Top 3 Sector Holdings | 99.9% | 99.32% | 99.85% | 99.9% | 99.9% | 100.27% |
| Top 5 Sector Holdings | 99.9% | 99.32% | 99.85% | 99.9% | 99.9% | 100.27% |
| Sector with Highest Exposure | Healthcare (99.9%) | Healthcare (99.32%) | Healthcare (99.85%) | Healthcare (99.9%) | Healthcare (99.9%) | Healthcare (100.27%) |
Top Stock Holdings
Sector Holdings in MF
Company Sector Assest(%) P/E EPS-TTM(₹) RETURN 1 YR(%) Sun Pharmaceutical Industries Healthcare 25.51 36.92 45.61 13.24 Cipla Healthcare 11.15 22.73 65.28 -0.15 Dr. Reddy's Laboratories Healthcare 10.1 18.15 67.77 4.85 Divi's Laboratories Healthcare 8.47 78.55 82.53 57.26 Lupin Healthcare 6.47 27.53 71.88 22.58 Aurobindo Pharma Healthcare 5.01 19.92 60.11 -3.07 Alkem Laboratories Healthcare 3.88 29.36 180.08 -3.00 Torrent Pharmaceuticals Healthcare 3.85 56.23 56.46 21.52 Zydus Lifesciences Healthcare 3.28 19.88 45.71 -15.56 Glenmark Pharmaceuticals Healthcare 3.09 38.27 37.11 37.08
Peer Comparison
Cumulative Returns
SIP returns
Discrete Returns
Quant Measures
Asset Allocation
Scheme Name NAV(Rs./Unit) Scheme Rating AUM(Rs. Cr) 1M 1Y 3Y 5Y ICICI Prudential Nifty Pharma Index Fund Direct - Growth 16.53 Unrated 83.25 -1.43 11.57 - - SBI Healthcare Opportunities Fund Direct Plan-Growth 477.35 3,670.62 -1.15 22.51 27.82 25.53 UTI Healthcare Fund Direct-Growth 309.35 1,037.49 0.39 21.99 24.59 23.09 Tata India Pharma & Healthcare Fund Direct-Growth 34.24 1,222.72 -0.28 16.29 24.52 23.62 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth 41.12 5,295.32 1.78 23.37 28.65 26.44
Risk Ratios
Ratios are calculated using the calendar month returns for the last 3 years
Risk Ratio data not available for this fund
ICICI Prudential Mutual Fund News
- MF Tracker: Can this mega largecap fund add stability to your portfolio in volatile market?
- NFO Monitor: ICICI Prudential Mutual Fund launches Nifty200 Quality 30 Index Fund
- ICICI Prudential Quality Fund opens for subscription. 8 things to know
- NFO Update: ICICI Prudential Mutual Fund launches quality fund
Fund Manager
- N.P.Nishit PatelSince Nov 202222 schemes
Mr. Patel is a B.Com & Chartered Accountant Prior to joining ICICI Prudential Mutual fund, he has worked with K.K.Dand & Co.
More ICICI Prudential Mutual Fund
| Scheme Name | Rating | Asset Size(Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| ICICI Prudential Bluechip Fund Direct-Growth | 68,033.76 | 4.74 | 9.27 | 6.14 | 12.05 | 22.85 | |
| ICICI Prudential Balanced Advantage Direct-Growth | 62,527.91 | 2.98 | 6.60 | 5.86 | 12.01 | 15.28 | |
| ICICI Prudential Multi Asset Fund Direct-Growth | 57,484.51 | 2.50 | 6.13 | 8.19 | 13.64 | 21.64 | |
| ICICI Prudential Liquid Fund Direct Plan-Growth | 53,192.63 | 0.51 | 1.79 | 3.59 | 7.34 | 6.95 | |
| ICICI Prudential Value Discovery Direct-Growth | 51,111.88 | 4.70 | 8.68 | 5.86 | 14.90 | 24.96 | |
| ICICI Prudential Equity & Debt Fund Direct-Growth | 42,339.71 | 3.11 | 8.82 | 7.32 | 12.95 | 22.31 | |
| ICICI Prudential Corporate Bond Fund Direct Plan -Growth | 31,133.02 | 0.98 | 3.34 | 5.17 | 9.64 | 8.25 | |
| ICICI Prudential Money Market Direct-Growth | 28,644.02 | 0.67 | 2.41 | 4.22 | 8.18 | 7.46 | |
| ICICI Prudential India Opportunities Fund Direct - Growth | 27,197.33 | 4.56 | 8.56 | 6.60 | 15.98 | 28.76 | |
| ICICI Prudential Equity Arbitrage Direct-Growth | 26,917.80 | 0.44 | 1.86 | 3.63 | 7.75 | 7.36 |
Mutual Fund Tools
Top AMCs
- SBI Mutual Fund
- ICICI Prudential Mutual Fund
- HDFC Mutual Fund
- Nippon India Mutual Fund
- Kotak Mahindra Mutual Fund
- Aditya Birla Sun Life Mutual Fund
- UTI Mutual Fund
- Axis Mutual Fund
- Mirae Asset Mutual Fund
- Tata Mutual Fund
- DSP Mutual Fund
- Bandhan Mutual Fund
- Edelweiss Mutual Fund
- HSBC Mutual Fund
- Franklin Templeton Mutual Fund
About ICICI Prudential Nifty Pharma Index Fund Direct - Growth
1. ICICI Prudential Nifty Pharma Index Fund - Direct Plan is Open-ended Sectoral-Pharma Equity scheme which belongs to ICICI Prudential Mutual Fund House.
2. The fund was launched on Dec 14, 2022.
Investment objective & Benchmark
1. The investment objective of the fund is that " The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index "
2. It is benchmarked against NIFTY Pharma Total Return Index.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 99.9% in equities, 0.0% in debts and 0.1% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 80.81% of the assets, the top 3 sectors constitute around 99.9% of the assets.
3. The fund largely follows a Blend oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on ICICI Prudential Nifty Pharma Index Fund Direct - Growth
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.
1. ICICI Prudential Nifty Pharma Index Fund - Direct Plan is Open-ended Sectoral-Pharma Equity scheme which belongs to ICICI Prudential Mutual Fund House.
2. The fund was launched on Dec 14, 2022.
Investment objective & Benchmark
1. The investment objective of the fund is that " The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index "
2. It is benchmarked against NIFTY Pharma Total Return Index.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 99.9% in equities, 0.0% in debts and 0.1% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 80.81% of the assets, the top 3 sectors constitute around 99.9% of the assets.
3. The fund largely follows a Blend oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on ICICI Prudential Nifty Pharma Index Fund Direct - Growth
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.
This Might Catch Your Interest
FAQs about ICICI Prudential Nifty Pharma Index Fund Direct - Growth
- Is it safe to invest in ICICI Prudential Nifty Pharma Index Fund - Direct Plan?As per SEBI’s latest guidelines to calculate risk grades, investment in the ICICI Prudential Nifty Pharma Index Fund - Direct Plan comes under Very High risk category.
- What is the category of ICICI Prudential Nifty Pharma Index Fund - Direct Plan?ICICI Prudential Nifty Pharma Index Fund - Direct Plan belongs to the Equity : Sectoral-Pharma category of funds.
- How Long should I Invest in ICICI Prudential Nifty Pharma Index Fund - Direct Plan?The suggested investment horizon of investing into ICICI Prudential Nifty Pharma Index Fund - Direct Plan is >3 years. The suggested investment horizon is the minimum time required for holding investments in the fund to reduce its downside risk and ensure that the returns become more predictable.
- Who manages the ICICI Prudential Nifty Pharma Index Fund - Direct Plan?The ICICI Prudential Nifty Pharma Index Fund - Direct Plan is managed by Nishit Patel (Since Nov 25, 2022).
Date Sources: Mutual Funds, ETFs, and NPS data are sourced from Value Research. All times stamps are reflecting IST (Indian Standard Time). By using this site, you agree to the Terms of Service and Privacy Policy.
